ask="N/A"
ask_size="N/A"
average_daily_volume="253172"
bid="7.14"
bid_size="100"
book_value="2.66"
change="-0.13"
change_from_200_day_moving_average="1.10"
change_from_50_day_moving_average="0.02"
change_from_52_week_high="-1.06"
change_From_52_week_low="3.01"
change_in_percent="-1.28%"
close="10.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.30"
ebitda="-117.58M"
eps_estimate_current_year="-2.03"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.73"
ex_dividend_date="N/A"
float_shares="14445000"
high="10.15"
high_52_weeks="11.07"
last_trade_date="2/22/2017"
last_trade_price="10.01"
last_trade_size="4764"
last_trade_time="4:00pm"
low="9.95"
low_52_weeks="7.00"
market_capitalization="183.18M"
moving_average_200_day="8.91"
moving_average_50_day="9.99"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="10.13"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+12.29%"
percent_change_from_50_day_moving_average="+0.21%"
percent_change_from_52_week_high="-9.58%"
percent_change_from_52_week_low="+43.00%"
previous_close="10.14"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.82"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18300000"
short_ratio="7.05"
stock_exchange="NGM"
symbol="AKBA"
volume="120337"
weeks_range_52="7.00 - 11.07"
